- Report
- October 2025
- 82 Pages
Qatar
From €4393EUR$4,850USD£3,790GBP
- Report
- October 2025
- 87 Pages
South Korea
From €4393EUR$4,850USD£3,790GBP
- Report
- June 2025
- 80 Pages
From €3125EUR$3,450USD£2,696GBP
- Report
- June 2025
- 180 Pages
Global
From €3623EUR$4,000USD£3,126GBP
- Report
- February 2025
- 135 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- January 2025
- 50 Pages
Global
From €2264EUR$2,499USD£1,953GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$5,901USD£4,456GBP
- Report
- December 2024
- 55 Pages
Global
From €2264EUR$2,499USD£1,953GBP
- Report
- October 2024
- 83 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- September 2024
- 118 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- May 2024
- 40 Pages
Global
From €630EUR$695USD£543GBP
- Report
- January 2024
- 201 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- October 2023
- 85 Pages
United States
From €4393EUR$4,850USD£3,790GBP
- Report
- August 2023
- 180 Pages
Global
From €3397EUR$3,750USD£2,931GBP
- Report
- July 2023
- 100 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €9053EUR$9,995USD£7,811GBP
- Report
- September 2022
Global
€4990EUR$5,901USD£4,456GBP
- Report
- September 2022
- 240 Pages
Global
From €5027EUR$5,550USD£4,337GBP
- Report
- June 2022
- 220 Pages
Global
From €3125EUR$3,450USD£2,696GBP
- Report
- November 2020
- 450 Pages
Global
From €4438EUR$4,900USD£3,829GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more